Analysts Are Bullish On These 4 Penny Stocks We’ve discussed penny stocks and analyst ratings many times before. Are these firms always correct about the companies they cover? No, but the information they offer doesn’t hurt when it comes to research. These firms will often dive into individual stocks to determine what the future might hold based on current developments at the time. They’ll look at things like the business pipeline and see what type of potential could be on the horizon. One thing to consider when it comes to ratings is that smaller stocks are much more speculative in nature. This means that the outlook “today” might not be the same outlook a few months from then. What’s more, price targets can also be a bit conflicting. Yesterday, for instance, we discussed a company with shares trading below $4, yet analysts set a $21 price target on the stock. The highest the particular company’s stock had ever traded was $12.70. Did the analyst see so much potential that it would value the company at nearly 100% higher than its all-time high? I’ll leave that decision up to you. But it is important to have a realistic approach to analyst ratings. Now, moving onto this list of penny stocks. Today there’s been a flurry of new ratings issued by a few firms, and so far, the new price targets set appear very bullish. While many of the companies have several irons on the fire, it’s important to remember that they’re still penny stocks, and volatility plays a large role. Based on recent analyst opinions, heading into the rest of the quarter, will they be on your list of penny stocks to buy right now or avoid? Penny Stocks To Buy [According To Analysts] Rigel Pharmaceuticals Inc. (NASDAQ: RIGL)Infinity Pharmaceuticals Inc. (NASDAQ: INFI)VistaGen Therapeutics Inc. (NASDAQ: VTGN)Titan Pharmaceuticals Inc. (NASDAQ: TTNP)Read Full: Penny Stocks To Buy With Analysts Targeting 76%-209% Upside